Christian Zurth - Concepedia

Author

Christian Zurth

Bayer (Germany)ORCID

Also Known As

C. Zurth, C.R. Zurth, CHRISTIAN ZURTH, Christian Zurth

Publications

750

Citations

H-Index

Concepts

All Affiliations

Bayer (Germany)Orion Corporation (Finland)Bayer (United States)Bayer (Japan)King's College London

About

Christian Zurth is an author at Bayer (Germany) specializing in medicine, pharmacology, and pharmacotherapy.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	6	6	187
2	Health Sciences	3	3	124
3	Endocrinology	3	3	111
4	Public Health	1	1	15
5	Social Sciences	1	1	15

Christian Zurth

Publications

594

Citations

H-Index

Page 1

	Year	Citations
Drug–Drug Interaction Potential of Darolutamide: In Vitro and Clinical Studies Christian Zurth, Mikko Koskinen, Robert E. Fricke, European Journal of Drug Metabolism and Pharmacokinetics	2019	94
Evaluation of Clinically Relevant Drug–Drug Interactions and Population Pharmacokinetics of Darolutamide in Patients with Nonmetastatic Castration-Resistant Prostate Cancer: Results of Pre-Specified and Post Hoc Analyses of the Phase III ARAMIS Trial Neal D. Shore, Christian Zurth, Robert E. Fricke, Targeted Oncology	2019	90
Ovulation‐Inhibiting Effects of Dienogest in a Randomized, Dose‐Controlled Pharmacodynamic Trial of Healthy Women Christine Klipping, Ingrid Duijkers, Ageeth Remmers, The Journal of Clinical Pharmacology	2011	88
Pharmacokinetics of single dose radium-223 dichloride (BAY 88-8223) in Japanese patients with castration-resistant prostate cancer and bone metastases Keisuke Yoshida, Tomohiro Kaneta, Shoko Takano, Annals of Nuclear Medicine	2016	61
Higher blood–brain barrier penetration of [<sup>14</sup>C]apalutamide and [<sup>14</sup>C]enzalutamide compared to [<sup>14</sup>C]darolutamide in rats using whole-body autoradiography. Christian Zurth, Steffen Sandman, Dagmar Trummel, Journal of Clinical Oncology Moderate Bbb PenetrationPharmacotherapyExperimental PharmacologyPre-clinical PharmacologyCerebral Vascular Regulation	2019	51
Blood-brain barrier penetration of [14C]darolutamide compared with [14C]enzalutamide in rats using whole body autoradiography. Christian Zurth, Steffen Sandmann, Dagmar Trummel, Journal of Clinical Oncology Pain MedicinePharmacotherapyExperimental PharmacologyPre-clinical PharmacologyMolecular Pharmacology	2018	45
Phase 1 study of darolutamide (ODM-201): a new-generation androgen receptor antagonist, in Japanese patients with metastatic castration-resistant prostate cancer Nobuaki Matsubara, Hirofumi Mukai, Ako Hosono, Cancer Chemotherapy and Pharmacology UrologyGenitourinary CancerMedicinePharmacologyPharmacotherapy	2017	33
Mechanism of Renal Excretion of Various X-ray Contrast Materials in Rabbits Christian Zurth Investigative Radiology Renal PathologyNephrologyX-ray ImagingRenal FunctionBioanalysis	1984	28
Comparison of Cerebral Blood Flow in Regions Relevant to Cognition After Enzalutamide, Darolutamide, and Placebo in Healthy Volunteers: A Randomized Crossover Trial Steven Williams, Ndaba Mazibuko, Owen O’Daly, Targeted Oncology	2023	23
Pharmacokinetic overview of ethinyl estradiol dose and bioavailability using two transdermal contraceptive systems and a standard combined oral contraceptive Birte Maria Hofmann, Isabel Reinecke, Barbara Schuett, International Journal of Clinical Pharmacology and Therapeutics	2014	16

Page 1